MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.010
-0.040 (-1.31%)
At close: Apr 28, 2026, 4:00 PM EDT
3.040
+0.030 (1.00%)
After-hours: Apr 28, 2026, 7:42 PM EDT
MacroGenics Revenue
In the year 2025, MacroGenics had annual revenue of $149.50M, down -0.31%. MacroGenics had revenue of $41.23M in the quarter ending December 31, 2025, with 113.03% growth.
Revenue (ttm)
$149.50M
Revenue Growth
-0.31%
P/S Ratio
1.28
Revenue / Employee
$510,239
Employees
293
Market Cap
191.32M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 149.50M | -462.00K | -0.31% |
| Dec 31, 2024 | 149.96M | 91.21M | 155.26% |
| Dec 31, 2023 | 58.75M | -93.19M | -61.33% |
| Dec 31, 2022 | 151.94M | 74.49M | 96.19% |
| Dec 31, 2021 | 77.45M | -27.44M | -26.16% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMGNX News
- 20 days ago - FDA Removes Partial Clinical Hold on MacroGenics' LINNET Study - GlobeNewsWire
- 6 weeks ago - MacroGenics Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 6 weeks ago - MacroGenics Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 7 weeks ago - MacroGenics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures - GlobeNewsWire
- 2 months ago - MacroGenics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - MacroGenics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial - GlobeNewsWire